Dr. Jorg Taubel will be attending the EPI | Lifestyle Scientific Sessions 2024. Taking place from 18th to 21st March in Chicago, Illinois, this event is a cornerstone for professionals in the field of epidemiology, prevention, and lifestyle medicine, with a particular focus on cardiometabolic health.
Dr. Taubel's presence at the conference promises to enrich the discussions and debates surrounding epidemiological cardiovascular issues and the impact of lifestyle trends. We anticipate engaging sessions that delve deep into understanding and addressing the intersection of lifestyle factors and cardiovascular health.
Participant-Centred Recruitment and Retention: Driving Faster Answers in Clinical Trials.
December 18, 2025
Richmond Pharmacology is proud to announce the publication of an editorial by Elizabeth Romano, Director of Communications and Participant Engagement, in the Winter 2025 issue of the Journal for Clinical Studies.
Richmond Pharmacology will attend JSCPT 2025 in Tokyo, represented by their leadership team. Topics include early-phase studies, bridging studies between Europe and Asia, gene and RNA-based therapy development, and cross-border collaboration.
By clicking “Accept”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.
.svg){kind=small}
.avif)
